GSK files Nucala for wider paediatric use

20th November 2018 Uncategorised 0

GlaxoSmithKline is seeking to expand the use of its biologic Nucala in the US to include children aged six to 11 years with severe eosinophilic asthma.

More: GSK files Nucala for wider paediatric use
Source: News